NEXGENRX INC (NXG.CA) Stock Price, Forecast & Analysis
Canada - TSX Venture Exchange - TSX-V:NXG - CA65337X1042 - Common Stock
NXG.CA Key Statistics, Chart & Performance
The current stock price of NXG.CA is 0.4 CAD. In the past month the price increased by 5.26%. In the past year, price increased by 60%.
NXG.CA Competitors/Peers
Related stock screener links
About NXG.CA
Company Profile
NexgenRx, Inc. engages in the provision of administrative services only (ASO) (Self-Funded) drug, dental and extended health benefit plans supported by technology. The company is headquartered in Toronto, Ontario. The company went IPO on 2006-09-14. The firm administers, adjudicates and pays drug, dental and other extended healthcare claims for the beneficiaries of health benefit plans underwritten by its customers, using proprietary computer software and also providing ancillary services. The company offers plan sponsors, providers and patient support program/drug manufacturers a full suite of software-as-a-service solutions. The Company’s products include NexSys, NexAdmin, and NexPSPAssist. The NexSys is a fully integrated rules based adjudication platform for secure real-time processing of drug, dental and extended health benefit claims. Its NexAdmin product enables sponsors to take complete control of benefit plan administration. The NexPSPAssist service helps patient support programs (PSP) to optimize their deliverables to their manufacturer clients.
Company Info
NEXGENRX INC
191 The West Mall, Suite 905
TORONTO ONTARIO M9C 5L5 CA
CEO: Ronald Loucks
Employees: 0
Phone: 14166953393
NEXGENRX INC / NXG.CA FAQ
What does NEXGENRX INC do?
NexgenRx, Inc. engages in the provision of administrative services only (ASO) (Self-Funded) drug, dental and extended health benefit plans supported by technology. The company is headquartered in Toronto, Ontario. The company went IPO on 2006-09-14. The firm administers, adjudicates and pays drug, dental and other extended healthcare claims for the beneficiaries of health benefit plans underwritten by its customers, using proprietary computer software and also providing ancillary services. The company offers plan sponsors, providers and patient support program/drug manufacturers a full suite of software-as-a-service solutions. The Company’s products include NexSys, NexAdmin, and NexPSPAssist. The NexSys is a fully integrated rules based adjudication platform for secure real-time processing of drug, dental and extended health benefit claims. Its NexAdmin product enables sponsors to take complete control of benefit plan administration. The NexPSPAssist service helps patient support programs (PSP) to optimize their deliverables to their manufacturer clients.
Can you provide the latest stock price for NEXGENRX INC?
The current stock price of NXG.CA is 0.4 CAD. The price increased by 8.11% in the last trading session.
Does NEXGENRX INC pay dividends?
NEXGENRX INC (NXG.CA) has a dividend yield of 2.54%. The yearly dividend amount is currently 0.01.
What is the ChartMill technical and fundamental rating of NXG stock?
NXG.CA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the Price/Earnings (PE) ratio of NEXGENRX INC (NXG.CA)?
The PE ratio for NEXGENRX INC (NXG.CA) is 20. This is based on the reported non-GAAP earnings per share of 0.02 and the current share price of 0.4 CAD.
How many employees does NEXGENRX INC have?
NEXGENRX INC (NXG.CA) currently has 0 employees.
NXG.CA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to NXG.CA. When comparing the yearly performance of all stocks, NXG.CA is one of the better performing stocks in the market, outperforming 76.13% of all stocks.
NXG.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to NXG.CA. Both the profitability and the financial health of NXG.CA get a neutral evaluation. Nothing too spectacular is happening here.
NXG.CA Financial Highlights
Over the last trailing twelve months NXG.CA reported a non-GAAP Earnings per Share(EPS) of 0.02. The EPS increased by 425% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 7.7% | ||
| ROA | 3.43% | ||
| ROE | 16.21% | ||
| Debt/Equity | 0.05 |